Correlation between brain nitric oxide synthase activity and opiate withdrawal

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 353, Issue 3, 1996, Pages 349-354

  Leza, Juan Carlos ^a   Lizasoain, Ignacio ^a   Cuéllar, Beatriz ^a   Moro, María A ^a   Lorenzo, Pedro ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Nitric oxide; Nitric oxide synthase; Opiate dependence; Opiate withdrawal

Indexed keywords

ARGININE; DEXTRO ARGININE; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CEREBELLUM; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME ACTIVITY; JUMPING; MALE; MORPHINE ADDICTION; MOTOR ACTIVITY; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ANIMALS; ARGININE; CEREBELLUM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STEREOISOMERISM; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030001944     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00168639     Document Type: Article

References (42)

1. G-nitro-L-arginine methyl ester. Life Sci 52:245-249
2. Aghajanian GK, Kogan JH, Moghaddam B (1994) Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res 636:126-130
3. Baker TB, Tiffany ST (1985) Morphine tolerance as habituation. Psychol Rev 92:78-108
4. Bianchetti A, Giudice A, Nava F, Manara L (1986) Dissociation of morphine withdrawal diarrhea and jumping in mice by the peripherally selective opioid antagonist SR 58001 C. Life Sci 39:2297-2303
5. Blasig J, Herz A, Reinhold K, Zieglgansberger S (1973) Development of physical dependence of morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33:19-38
6. Bliss TVP, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39
7. Bredt DS, Snyder SH (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86:9030-9033
8. Calignano A, Persico P, Mancuso F, Sorrentino L (1993) Endogenous nitric oxide modulates morphine-induced changes in locomotion and food intake in mice. Eur J Pharmacol 231:415-419
9. Cappendijk SLT, de Vries R, Dzoljic MR (1993) Inhibitory effects of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci Lett 162:97-100
10. Cappendijk SLT, Garrelds IM, Dzoljic MR (1994) Nitric oxide in the nervous system. Laurentians Mountains, Montreal, Canada, July 1994. Abstracts pp 1. 18
11. Cappendijk SLT, Duval SY, de Vries R, Dzoljic MR (1995) Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats. Neurosci Lett 183:67-70
12. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634
13. Cooper JR, Bloom FE, Roth RH (1991) Norepinephrine and epinephrine. In: Cooper JR, Bloom FE, Roth RH (eds) The biochemical basis of neuropharmacology. Oxford University Press, New York, pp 220-461
14. De Sarro GG, Donato Di Paola E, De Sarro A, Vidal MJ (1993) L-arginine potentiates excitatory amino acid-induced seizures in the deep prepiriform cortex. Eur J Pharmacol 230:151-158
15. Garthwaite J (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14:60-67
16. Garthwaite J (1993) Nitric oxide signalling in the nervous system. Semin Neurosci 5:171-180
17. Garthwaite J, Charles SL, Chess-Williams R (1988) Endothelium-derived relaxing factor release on activation of NMDA receptor suggests a role as intracellular messenger in the brain. Nature 336:385-388
18. Gibson RD, Tingstad TE (1970) Formulation of a morphine implantation pellet suitable for tolerance-physical dependence studies in mice. J Pharm Sci 59:42642-42647
19. G-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem Biophys Res Commun 167:1037-1043
20. Kimes AS, Vaupel DB, London DF. (1993) Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology 112:521-524
21. Kolesnikov YA, Pick CG, Ciszewska G, Pasternak GW (1993) Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 90:5162-5166
22. Laschka E, Herz A, Blasig J (1976) Sites of action of morphine involved in the development of physical dependence in rats I. Comparison of precipitated morphine withdrawal after intraperitoneal and intraventricular injection of morphine antagonists. Psychopharmacologia 46:133-139
23. Maldonado R, Stinus L, Gold LH, Koob GF (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261:669-677
24. Meldrum B, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11:379-387
25. Mollace V, Bagetta G, Nistico G (1991) Evidence that L-arginine possesses proconvulsant effects mediated though nitric oxide. Neuroreport 2:269-272
26. Moncada S, Palmer RMJ, Higgs EA (1989) Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 38:1709-1715
27. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, patophysiology and pharmacology. Pharmacol Rev 43:109-142
28. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 102:198-202
29. Navarro M, Lizasoain I, Leza JC, Lorenzo P (1991) An original method for assessment of the jumping test. Methods Find Exp Clin Pharmacol 13:443-447
30. Przewlocki R, Machelska H, Przewlocka B (1994) Modulation of morphine and cocaine effects by inhibition of nitric oxide synthase. Regul Pept 54:233-235
31. Rasmussen K, Fuller RW, Stockton ME, Perry KW, Swinford RM, Ornstein PL (1991a) NMDA receptor antagonists supress behaviors but not norepinephrine turnover of locus coeruleus unit activity induced by opiate withdrawal. Eur J Pharmacol 197:9-16
32. Rasmussen K, Krystal JH, Aghajanian GK (1991b) Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration. Psychopharmacology 105:508-512
33. Redmond DE, Krystal JH (1984) Multiple mechanisms of withdrawal from opioid drugs. Ann Rev Neurosci 7:443-478
34. Rodrigo J, Springall DR, Uttenthal O, Bentura ML, Abadia-Molina F, Riveros-Moreno V, Martínez-Murillo R, Polak JM, Moncada S (1994) Localization of nitric oxide in the adult rat brain. Phil Trans R Soc Lond B 345:175-221
35. Saelens JK, Granat FR, Sawyer WK (1971) The mouse jumping test. A simple screening method to estimate the physical dependence capacity of analgesics. Arch Int Pharmacodyn Ther 190:213-218
36. 2+-independent nitric oxide synthases. FEBS Lett 291:145-149
37. Shibuki K, Okada D (1991) Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349:326-328
38. Tanganelli S, Antonelli T, Morari M, Bianchi C, Beani L (1991) Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci Lett 122:270-272
39. G-monomethyl L-arginine and MK-801 on the abstinence syndrome in morphine dependent mice. Brain Res 642:153-159
40. Trujillo KA, Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87
41. Tung CS, Grenhoff J, Svensson TH (1990) Morphine withdrawal responses of rat locus coeruleus neurons are blocked by an excitatory amino-acid antagonist. Acta Physiol Scand 138:581-582
42. Xu ZQ, Pieribone VA, Zhang X, Grillner S, Hökfelt T (1994) A functional role for nitric oxide in locus coeruleus: immunohistochemical and electrophysiological studies. Exp Brain Res 98:75-83